For research use only. We do not sell to patients.
Lin28-let-7a antagonist 1
CAS No. : 2024548-03-4
Biological Activity：Lin28-let-7a antagonist 1 shows a clear antagonistic effect against the Lin28-let-7a interaction with an IC50 of 4.03 μM for Lin28A-let-7a-1 interaction.
Research Area：Cancer
Targets：MicroRNA
Related Screening Libraries:Bioactive Compound Library Plus;Epigenetics Compound Library;Anti-Cancer Compound Library;Transcription Factor-Targeted Library;
Related Small Molecules:(R)-Camptothecin-d5;Targaprimir-96 TFA;Camptothecin;Miravirsen;microRNA-21-IN-2;MIR96-IN-1;Gypenoside LI;Aurintricarboxylic acid;PIN1 inhibitor 2;LIN28 inhibitor LI71;Pseudoprotodioscin;Cl-amidine TFA;SID 3712249;RJW100;PIN1 inhibitor API-1;RG-101;TGP-377/421;Camptothecin-d5;Lademirsen;Targapremir-210;microRNA-21-IN-1
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
